BMT is used to treat cancers like leukemia, lymphoma, multiple myeloma, as well as bone marrow failure syndromes (aplastic anemia, congenital neutropenia), inherited blood disorders (thalassemia, sickle cell disease), and severe immune deficiencies.

Autologous BMT uses the patient’s own stem cells, usually in cases where high-dose chemotherapy is required. Allogenic BMT uses stem cells from a donor, typically recommended for genetic or acquired marrow disorders where healthy donor cells are essential.

Haploidentical transplant uses a half-matched family donor (like a parent or child). T-cell depletion techniques (in vivo or in vitro) reduce the risk of graft-versus-host disease while allowing more patients access to transplant.

Risks include infections, bleeding, organ complications, and graft-versus-host disease (GVHD). At Pasola International, patients are closely monitored, and preventive strategies are applied to minimize these risks.

Recovery varies but generally requires several weeks of hospitalization, followed by months of close monitoring. Patients gradually regain strength as their immune system rebuilds.

We provide complete support including counseling, nutritional guidance, physiotherapy, psychological care, and long-term follow-up programs to ensure patients and their families feel cared for at every stage.